Works matching IS 11707690 AND DT 2022 AND VI 40 AND IP 3

Results: 10

Correction to: Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 357, doi. 10.1007/s40273-022-01134-w

By:

Morillon, Gabin F.;
Poder, Thomas G.

Publication type:

Article

Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.

Published in:

2022

By:

Mattingly II, T. Joseph;
McQueen, R. Brett;
Lin, Pei-Jung

Publication type:

Correction Notice

Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 341, doi. 10.1007/s40273-021-01124-4

By:

Morillon, Gabin F.;
Poder, Thomas G.

Publication type:

Article

Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 269, doi. 10.1007/s40273-021-01120-8

By:

Romano, Sónia;
Figueira, Débora;
Teixeira, Inês;
Perelman, Julian

Publication type:

Article

Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 249, doi. 10.1007/s40273-021-01116-4

By:

Shields, Gemma E.;
Pennington, Becky;
Bullement, Ash;
Wright, Stuart;
Elvidge, Jamie

Publication type:

Article

Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 257, doi. 10.1007/s40273-021-01113-7

By:

Huang, Min;
Ramsey, Scott;
Xue, Weiguang;
Xie, Jipan;
Pellissier, James;
Briggs, Andrew

Publication type:

Article

Four Aspects Affecting Health Economic Decision Models and Their Validation.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 241, doi. 10.1007/s40273-021-01110-w

By:

Feenstra, Talitha;
Corro-Ramos, Isaac;
Hamerlijnck, Dominique;
van Voorn, George;
Ghabri, Salah

Publication type:

Article

A Comparison of PROPr and EQ-5D-5L Value Sets.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 297, doi. 10.1007/s40273-021-01109-3

By:

Pan, Tianxin;
Mulhern, Brendan;
Viney, Rosalie;
Norman, Richard;
Hanmer, Janel;
Devlin, Nancy

Publication type:

Article

Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 309, doi. 10.1007/s40273-021-01101-x

By:

Yang, Fan;
Katumba, Kenneth R.;
Roudijk, Bram;
Yang, Zhihao;
Revill, Paul;
Griffin, Susan;
Ochanda, Perez N.;
Lamorde, Mohammed;
Greco, Giulia;
Seeley, Janet;
Sculpher, Mark

Publication type:

Article

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom.

Published in:

PharmacoEconomics, 2022, v. 40, n. 3, p. 323, doi. 10.1007/s40273-021-01106-6

By:

Spelman, Timothy;
Herring, William L.;
Zhang, Yuanhui;
Tempest, Michael;
Pearson, Isobel;
Freudensprung, Ulrich;
Acosta, Carlos;
Dort, Thibaut;
Hyde, Robert;
Havrdova, Eva;
Horakova, Dana;
Trojano, Maria;
De Luca, Giovanna;
Lugaresi, Alessandra;
Izquierdo, Guillermo;
Grammond, Pierre;
Duquette, Pierre;
Alroughani, Raed;
Pucci, Eugenio;
Granella, Franco

Publication type:

Article